LUX-Lung 8: A Randomized, Open-label Phase III Trial of Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung as Second-line Therapy Following First-line Platinum-based Chemotherapy
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Progression-free survival, as determined by RECIST 1.1
18 months
No
Boehringer Ingelheim
Study Chair
Boehringer Ingelheim Pharmaceuticals
Argentina: Admin Nacional de Medicamentos, Alimentos Tecnologia Medica
1200.125
NCT01523587
March 2012
January 2015
Name | Location |
---|---|
1200.125.10034 Boehringer Ingelheim Investigational Site | Alhambra, California |
1200.125.10025 Boehringer Ingelheim Investigational Site | Burbank, California |
1200.125.10041 Boehringer Ingelheim Investigational Site | La Jolla, California |
1200.125.10019 Boehringer Ingelheim Investigational Site | Sacramento, California |
1200.125.10017 Boehringer Ingelheim Investigational Site | Norwalk, Connecticut |
1200.125.10058 Boehringer Ingelheim Investigational Site | Southington, Connecticut |
1200.125.10009 Boehringer Ingelheim Investigational Site | Lake City, Florida |
1200.125.10004 Boehringer Ingelheim Investigational Site | Athens, Georgia |
1200.125.10011 Boehringer Ingelheim Investigational Site | Skokie, Illinois |
1200.125.10028 Boehringer Ingelheim Investigational Site | Detroit, Michigan |
1200.125.10015 Boehringer Ingelheim Investigational Site | Fresh Meadows, New York |
1200.125.10063 Boehringer Ingelheim Investigational Site | DuBois, Pennsylvania |
1200.125.10059 Boehringer Ingelheim Investigational Site | Kingston, Pennsylvania |
1200.125.10016 Boehringer Ingelheim Investigational Site | Spartanburg, South Carolina |
1200.125.10055 Boehringer Ingelheim Investigational Site | Paris, Texas |
1200.125.10051 Boehringer Ingelheim Investigational Site | Christianburg, Virginia |
1200.125.10052 Boehringer Ingelheim Investigational Site | Seattle, Washington |
1200.125.10073 Boehringer Ingelheim Investigational Site | Chandler, Arizona |
1200.125.10039 Boehringer Ingelheim Investigational Site | Corona, California |
1200.125.10046 Boehringer Ingelheim Investigational Site | Los Angeles, California |
1200.125.10087 Boehringer Ingelheim Investigational Site | Montebello, California |
1200.125.10031 Boehringer Ingelheim Investigational Site | Orange, California |
1200.125.10002 Boehringer Ingelheim Investigational Site | Riverside, California |
1200.125.10076 Boehringer Ingelheim Investigational Site | Fort Collins, Colorado |
1200.125.10085 Boehringer Ingelheim Investigational Site | Stamford, Connecticut |
1200.125.10067 Boehringer Ingelheim Investigational Site | Boca Raton, Florida |
1200.125.10080 Boehringer Ingelheim Investigational Site | Brooksville, Florida |
1200.125.10066 Boehringer Ingelheim Investigational Site | Hollywood, Florida |
1200.125.10027 Boehringer Ingelheim Investigational Site | Lakeland, Florida |
1200.125.10081 Boehringer Ingelheim Investigational Site | New Port Richey, Florida |
1200.125.10086 Boehringer Ingelheim Investigational Site | New Port Richey, Florida |
1200.125.10064 Boehringer Ingelheim Investigational Site | Niles, Illinois |
1200.125.10018 Boehringer Ingelheim Investigational Site | Urbana, Illinois |
1200.125.10054 Boehringer Ingelheim Investigational Site | Lafayette, Indiana |
1200.125.10032 Boehringer Ingelheim Investigational Site | Louisville, Kentucky |
1200.125.10083 Boehringer Ingelheim Investigational Site | Marrero, Louisiana |
1200.125.10048 Boehringer Ingelheim Investigational Site | Burlington, Massachusetts |
1200.125.10072 Boehringer Ingelheim Investigational Site | Lawrence, Massachusetts |
1200.125.10060 Boehringer Ingelheim Investigational Site | St. Joseph, Missouri |
1200.125.10057 Boehringer Ingelheim Investigational Site | St. Louis, Missouri |
1200.125.10077 Boehringer Ingelheim Investigational Site | Billings, Montana |
1200.125.10069 Boehringer Ingelheim Investigational Site | Bronx, New York |
1200.125.10029 Boehringer Ingelheim Investigational Site | New York, New York |
1200.125.10062 Boehringer Ingelheim Investigational Site | Syracuse, New York |
1200.125.10024 Boehringer Ingelheim Investigational Site | Cleveland, Ohio |
1200.125.10050 Boehringer Ingelheim Investigational Site | Columbus, Ohio |
1200.125.10070 Boehringer Ingelheim Investigational Site | Columbus, Ohio |
1200.125.10023 Boehringer Ingelheim Investigational Site | Portland, Oregon |
1200.125.10040 Boehringer Ingelheim Investigational Site | Portland, Oregon |
1200.125.10078 Boehringer Ingelheim Investigational Site | Philadelphia, Pennsylvania |
1200.125.10079 Boehringer Ingelheim Investigational Site | Philadelphia, Pennsylvania |
1200.125.10068 Boehringer Ingelheim Investigational Site | Cookeville, Tennessee |
1200.125.10022 Boehringer Ingelheim Investigational Site | San Antonio, Texas |
1200.125.10091 Boehringer Ingelheim Investigational Site | Salt Lake City, Utah |
1200.125.10061 Boehringer Ingelheim Investigational Site | Burlington, Vermont |
1200.125.10074 Boehringer Ingelheim Investigational Site | Norfolk, Virginia |